Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency

Objective CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characteristics in Chinese children with cblC defect. Methods Children with cblC deficiency who manifested as kidney damage were enrolled. Clinical, renal pathological, and genetic data were reviewed in detail. Results Seven cases were enrolled. Ages at disease onset ranged from 9 months to 5 years. All patients presented with hematuria and proteinuria, and 2/7 cases presented with nephrotic syndrome. Renal dysfunction was observed in 4/7 cases. Renal biopsy was performed in 5/7 cases, and all of them had renal thrombotic microangiopathy. Macrocytic anemia was detected in all seven patients. Six out of seven cases had hypertension, and 2/7 cases presented with pulmonary hypertension. Two of them had a mild intellectual disability, and one suffered from epilepsy. Increased urine methylmalonic acid and plasma homocysteine were detected in seven cases, while two patients had normal levels of urine methylmalonic acid at the initial evaluation. After diagnosis, all seven cases were treated with hydroxocobalamin IM. Six cases were followed-up for 3–8 years. After treatments, anemia was the first to be recovered, followed by proteinuria. Renal function recovered after 1 year in two cases, whereas patient 2 progressed to stage 2 chronic kidney disease 13 years after onset. While a case presented with end-stage kidney disease because of late diagnosis, one case died 3 months after disease onset due to giving up treatment. Three MMACHC pathogenic variants c.80A > G (8/14), c.609G > A (4/14), and c.658_660delAAG (2/14) were detected in all seven children. Conclusion MMACHC variant c.80A > G may be associated with prominent renal complications in Chinese cblC patients. Macrocytic anemia and hyperhomocysteinemia are useful clues for patients with hematuria and proteinuria caused by cblC defect. The most frequent renal pathological manifestation is thrombotic microangiopathy. Early diagnosis and treatment resulted in improving renal and hematological signs.

[1]  Haiyan Yu,et al.  Case Report: A Rare Case of Thrombotic Microangiopathy Induced by Remethylation Disorders , 2022, Frontiers in Medicine.

[2]  Zhao Hu,et al.  Case Report: Membranous Nephropathy Secondary to Cobalamin C Disease , 2022, Frontiers in Medicine.

[3]  C. Dionisi-Vici,et al.  Ocular manifestations in patients with inborn errors of intracellular cobalamin metabolism: a systematic review , 2021, Human Genetics.

[4]  Xue-ming Zhu,et al.  Proteinuria as a presenting sign of combined methylmalonic acidemia and homocysteinemia: case report , 2020, BMC medical genetics.

[5]  Dong Li,et al.  Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review. , 2019, European journal of medical genetics.

[6]  X. Kong,et al.  Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria , 2018, BMC Medical Genetics.

[7]  D. Cassiman,et al.  Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy , 2018, Kidney international reports.

[8]  Dexuan Wang,et al.  Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia , 2017, Medicine.

[9]  Songming Huang,et al.  Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report , 2017, Experimental and therapeutic medicine.

[10]  F. Kok,et al.  Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls , 2017, Pediatric Nephrology.

[11]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[12]  A. Diepstra,et al.  Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity , 2016, Pediatric Nephrology.

[13]  W. Zein,et al.  Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency. , 2016, Ophthalmology.

[14]  A. Losito,et al.  Combined Pulmonary Hypertension and Renal Thrombotic Microangiopathy in Cobalamin C Deficiency , 2013, Pediatrics.

[15]  S. Testa,et al.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria , 2012, Pediatric Nephrology.

[16]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[17]  Xuefan Gu,et al.  Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China , 2010, Journal of Inherited Metabolic Disease.

[18]  K. Hsiao,et al.  Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.

[19]  M. Baumgartner,et al.  Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.

[20]  Susan L Furth,et al.  New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[21]  G. Uziel,et al.  Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.

[22]  C. Greenberg,et al.  Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder , 2007, Pediatric Nephrology.

[23]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.

[24]  D. C. Henckel,et al.  Case report. , 1995, Journal.